Loading clinical trials...
Loading clinical trials...
A Randomized, Multicenter, Double-blind, Placebocontrolled Study to Evaluate the Efficacy and Safety of 1.5 mg/kg Per Day of Sarecycline Compared to Placebo in the Treatment of Acne Vulgaris
Conditions
Interventions
Sarecycline
Placebo
Locations
57
United States
Warner Chilcott Research Site (Site #155)
Beverly Hills, California, United States
Warner Chilcott Research Site (Site #129)
Encino, California, United States
Warner Chilcott Research Site (Site #150)
La Mesa, California, United States
Warner Chilcott Research Site (Site #136)
Los Angeles, California, United States
Warner Chilcott Research Site (Site #147)
Sacramento, California, United States
Warner Chilcott Research Site (Site #123)
San Diego, California, United States
Start Date
December 18, 2014
Primary Completion Date
February 1, 2017
Completion Date
February 1, 2017
Last Updated
February 15, 2019
NCT07205107
NCT05891795
NCT06501560
NCT03883269
NCT07469228
NCT06415305
Lead Sponsor
Almirall, S.A.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions